Tag: National Institutes of Pharmaceutical Education & Research (NIPERs)

Pharma firms likely to post 11% growth in sales, EBITDA in Q1FY26: Report

In diagnostics, volume growth, better mix, and M&A activity are expected to contribute to a 14 per cent YoY sales increase across the coverage.

July 6, 2025